{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11"}]}],"title":"CD4+ : Blood"},{"categories":[{"measurements":[{"groupId":"OG000","value":"11"}]}],"title":"CD4+ : Bone Marrow"},{"categories":[{"measurements":[{"groupId":"OG000","value":"11"}]}],"title":"CD8+ : Blood"},{"categories":[{"measurements":[{"groupId":"OG000","value":"11"}]}],"title":"CD8+ : Bone Marrow"}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"}],"units":"Participants"}],"description":"Number of participants with engraftment in blood and bone marrow","groups":[{"description":"Participants who received NYESO-1ᶜ²⁵⁹T following ASCT","id":"OG000","title":"NYESO-1ᶜ²⁵⁹T Cells"}],"paramType":"NUMBER","populationDescription":"Participants who received NYESO-1ᶜ²⁵⁹T following ASCT with engraftment data.","reportingStatus":"POSTED","timeFrame":"Post Treatment","title":"Engraftment of Gene-modified Pentamer+ CD4+ T Cells and CD8+ T Cells","type":"SECONDARY","unitOfMeasure":"participants"}